Entheon Biomedical Corp.
Entheon Biomedical Corp.
CSE Index:
Currency:
Entheon is a biotechnology research and development company interested in treating addiction and substance use disorders.
Entheon Biomedical Corp. (ENBI)
(%)
*Financial charts powered by Quotemedia.com. All right reserved. View the Terms of Use. Data delayed 15 minutes unless indicated.
Company Info
Address
Suite 720-999 W Broadway Street
Vancouver, BC V5Z 1K5
CanadaPhone
604-562-3932Email
info@entheonbiomedical.comWebsite
https://entheonbiomedical.com/Listing date
Thursday, May 3, 2018Transfer Agent
Olympia Trust CompanyAuditor
Manning Elliott LLPSEDAR Information
Filing Type
Any
Timeframe
1 week1 month3 month6 month1 yearAll Time
Company Info
Address
Suite 720-999 W Broadway Street
Vancouver, BC V5Z 1K5
CanadaPhone
604-562-3932Email
info@entheonbiomedical.comWebsite
https://entheonbiomedical.com/Listing date
Thursday, May 3, 2018Transfer Agent
Olympia Trust CompanyAuditor
Manning Elliott LLPCapitalization
Issued & Outstanding:
13858934Reserved for Issuance:
8090000Company Officers
Timothy Ko, CEO
Soo-Whan Kim, Interim CFO
Kelly Pladson, Corporate Secretary
News Releases
Bulletins
28/02/2024
2024-0235 – Consolidation - Entheon Biomedical Corp. (ENBI)
Le 28 février/February 2024
Entheon Biomedical Corp. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated common share for every ten (10) pre-consolidated common shares.
As a result, the outstanding shares of the company will be reduced to approximately 5,908,926 common shares.
The name and symbol will not change.
